Antineoplastic Drugs: Cell-cycle specific Flashcards
Classes of Cell-cycle specific drugs
- Antimetabolites = Methotrexate AND Cytarabine
- Topoisomerase II Inhibitors = Etoposide
- Mitotic Inhibitors = Paclitaxel AND Vincristine
- Antineoplastic Enzymes = Asparaginase
Antimetabolites
MOA:
Have two phases: 1 . Inhibit cell growth by interfering with compounds needed for cell reproduction/synthesis - aka folic acid, purine and pyrimidine; 2. falsely substitute for purines, folic acid or pyrimidines
Indications:
Solid tumors, leukemias, & non-Hodgkin’s lymphoma
Adverse Effects:
Hair loss, nausea, vomiting, diarrhea, myelosuppression (Table 45-6)
Interactions:
Table 45-7
Nursing Considerations:
-educate on AEs like hair loss
Antimetabolites - Key Drugs
Methotrexate
- Treatment of solid tumors such as breast, head and neck, lung cancers, acute lymphocytic leukemia, and non- Hodgkin’s lymphomas
- Severe bone marrow suppression with high doses
- “Rescue” drug is LEUCOVORIN
Cytarabine
- Treatment of acute myelocytic and lymphocytic leukemia, and non-Hodgkin’s lymphomas
- Cytarabine syndrome (can treat with CORTICOSTEROIDS): fever, muscle and bone pain, maculopapular rash, conjunctivitis, and malaise
Topoisomerase II Inhibitors
MOA:
Inhibit enzyme topoisomerase II causing breaks in DNA strands
Indications:
Small cell lung cancer and testicular cancer
Adverse Effects:
Hair loss, nausea, vomiting
Interactions:
Table 45-9, warfarin and cyclosporine
Nursing Considerations:
- educate about possible bruising if on Warfarin
- educate about falls
Topoisomerase II Inhibitors - Key Drugs
Etoposide:
- Treatment of small cell lung cancer and testicular cancer
- Interactions with WARFARIN and CYCLOSPORINE
**topo-break in DNA- bleeding - entopo
Mitotic Inhibitors
MOA:
Work before or during cell mitosis to inhibit cell division
Indications:
Variety of solid tumors and some hematologic malignancies
Adverse Effects:
Hair loss, nausea, vomiting, myelosuppression
Interactions:
Table 45-9
Nursing Considerations:
- watch for common AEs
Mitotic Inhibitors - Key Drugs
Paclitaxel:
- Treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and Kaposi’s sarcoma
- Hypersensitivity associated with infusion (pre-treat); we PRE-TREAT with dexathemazone or H1 receptor antagonist like diphenhydramine or H2 receptor antagonist like renididine
Vincristine:
- Treatment of acute lymphocytic leukemia and other cancers
- Do NOT give via intrathecal route- fatal if administered this way!
**mitosis - blood cancer - P and V
Antineoplastic Enzymes
MOA:
Catalyzes conversion of asparagine to aspartic acid and ammonia, SO cancer cells can’t synthesize asparagine gene which is needed for DNA reproduction
Indications:
Acute lymphocytic leukemia
Adverse Effects:
Impaired pancreatic function, which can lead to HYPERGLYCEMIA and PANCREATITIS
Interactions:
Table 45-11
Nursing Considerations:
- check blood sugar
- teach s/s of hypergly
**Antineoplastic - A to A+A - no DNA - Leuko
Antineoplastic Enzymes - Key Drug
Asparaginase:
- Treatment of acute lymphocytic leukemia
- Derived from E. coli bacterium
- Common for patients to develop ALLERGIC reaction to it